Current Report Filing (8-k)
July 01 2014 - 4:32PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
July 1, 2014
Date
of report (Date of earliest event reported)
SOLAZYME,
INC.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware |
|
001-35189 |
|
33-1077078 |
(State or Other Jurisdiction of Incorporation) |
|
(Commission File Number) |
|
(I.R.S. Employer Identification Number) |
|
|
|
225 Gateway Boulevard
South San Francisco, CA 94080 |
|
|
|
94080 |
(Address of Principal Executive Offices) |
|
|
|
(Zip Code) |
(650) 780-4777
(Registrants Telephone Number, Including Area Code)
Not Applicable
(Former
name or former address, if changed since last report.)
Check the appropriate box below
if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (see General Instruction A.2 below):
¨ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 5.02(c) Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On July 1, 2014, Solazyme, Inc. (the Company) appointed Tyler W. Painter as the Companys Chief Operating Officer (in
addition to his current role as Chief Financial Officer), effective immediately, with an adjusted base salary of $450,000 per year, and an adjusted annual cash bonus target of 50% of base salary.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
SOLAZYME, INC. |
|
|
|
|
Date: July 1, 2014 |
|
|
|
By: |
|
/s/ Paul Quinlan |
|
|
|
|
|
|
Paul Quinlan |
|
|
|
|
|
|
General Counsel |